"How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor".

Albayrak, Haluk Cihad; Gürler, Fatih; Sütçüoglu, Osman; Akyürek, Nalan; Özet, Ahmet

Albayrak, Haluk Cihad; Gürler, Fatih; Sütçüoglu, Osman; Akyürek, Nalan; Özet, Ahmet.

Afiliación

Albayrak HC; Department of Internal Medicine.
Gürler F; Department of Medical Oncology.
Sütçüoglu O; Department of Medical Oncology.
Akyürek N; Department of Pathology, Gazi University, Ankara, Turkey.
Özet A; Department of Medical Oncology.

Anticancer Drugs ; 33(1): 109-111, 2022 01 01.

Article en En | MEDLINE | ID: mdl-34261914

Asunto(s)

Antineoplásicos/uso terapéutico; Crizotinib/uso terapéutico; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias de Tejido Muscular/tratamiento farmacológico; Quinasa de Linfoma Anaplásico/genética; Femenino; Humanos; Neoplasias Pulmonares/genética; Persona de Mediana Edad; Neoplasias de Tejido Muscular/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Crizotinib / Neoplasias Pulmonares / Neoplasias de Tejido Muscular / Antineoplásicos Límite: Female / Humans / Middle aged Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google